Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention.

[1]  P. Ponikowski,et al.  Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2008, Journal of the American College of Cardiology.

[2]  W. Markiewicz,et al.  Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. , 2007, European heart journal.

[3]  P. Ponikowski,et al.  Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. , 2007, Journal of the American College of Cardiology.

[4]  M. Zembala,et al.  Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention. , 2007, American heart journal.

[5]  R. Archbold,et al.  Hemoglobin concentration is an independent determinant of heart failure in acute coronary syndromes: cohort analysis of 2310 patients. , 2006, American heart journal.

[6]  C. Becker,et al.  Epidemiology and prognostic implications of contrast-induced nephropathy. , 2006, The American journal of cardiology.

[7]  V. Chopra,et al.  Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome. , 2006, The American journal of cardiology.

[8]  S. Solomon,et al.  Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program , 2006, Circulation.

[9]  R. Giugliano,et al.  Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes , 2005, Circulation.

[10]  J. Lindenfeld.  Prevalence of anemia and effects on mortality in patients with heart failure. , 2005, American heart journal.

[11]  J. J. Griffin,et al.  Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. , 2004, Journal of the American College of Cardiology.

[12]  G. Breithardt,et al.  Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. , 2003, European heart journal.

[13]  Paul W Armstrong,et al.  Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[14]  Alan C. Wilson,et al.  Effect of anemia on 1-year mortality in patients with acute myocardial infarction. , 2002, American heart journal.

[15]  J. Griffith,et al.  Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. , 2002, Journal of the American College of Cardiology.

[16]  H. Krumholz,et al.  Blood transfusion in elderly patients with acute myocardial infarction. , 2001, The New England journal of medicine.

[17]  I. Shapira,et al.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.

[18]  R. Weiskopf,et al.  Human cardiovascular and metabolic response to acute, severe isovolemic anemia. , 1998, JAMA.

[19]  G. Guyatt,et al.  Recognizing and investigating iron-deficiency anemia in hospitalized elderly people. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[20]  W. Kannel,et al.  Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up. , 1994, American heart journal.

[21]  G. J. Crystal,et al.  Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. , 1993, The American journal of physiology.

[22]  R Roberts,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.

[23]  H. Gewirtz,et al.  Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. , 1986, Circulation.

[24]  K. Jan,et al.  Effect of hematocrit variations on coronary hemodynamics and oxygen utilization. , 1977, The American journal of physiology.

[25]  G. Buckberg,et al.  The Adequacy of Subendocardial Oxygen Delivery: The Interaction of Determinants of Flow, Arterial Oxygen Content and Myocardial Oxygen Need , 1974, Circulation.

[26]  M. Hiele,et al.  Prevalence and causes of anaemia in a geriatric hospitalized population. , 1992, Gerontology.

[27]  W. J. Powell,et al.  Effect of acute anemia on experimental myocardial ischemia. , 1973, The American journal of cardiology.